Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer

Authors

Keywords

Journal

Volume -, Issue -, Pages -

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2021-08-27

DOI

10.1097/ju.0000000000002190

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation